Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | +0.86% | -16.43% | +37.65% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 175M | Capitalization | 349M |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -9M | EV / Sales 2024 * | 2.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2 x |
P/E ratio 2024 * |
-10.9
x | P/E ratio 2025 * |
-36.6
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.05% |
Latest transcript on Heron Therapeutics, Inc.
1 day | +1.08% | ||
1 week | -11.51% | ||
Current month | +1.08% | ||
1 month | -13.47% | ||
3 months | -2.29% | ||
6 months | +272.93% | ||
Current year | +37.94% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 2.34 | +0.86% | 2 175 000 |
24-04-30 | 2.32 | -7.20% | 2,329,041 |
24-04-29 | 2.5 | +2.04% | 1,859,972 |
24-04-26 | 2.45 | -3.92% | 2,311,863 |
24-04-25 | 2.55 | -3.77% | 2,197,081 |
Delayed Quote Nasdaq, May 01, 2024 at 01:25 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.94% | 349M | |
-0.08% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.55% | 24.63B | |
-23.64% | 18.2B | |
+27.85% | 12.01B | |
-3.03% | 11.76B | |
+14.88% | 10.4B | |
-5.03% | 9.94B |
- Stock Market
- Equities
- HRTX Stock